Search Results 1-10 of 17405 for GLP-1 medications

  1. Diabetes drugs and weight loss - Mayo Clinic

    GLP-1 agonists mimic the way a hormone called glucagon-like peptide 1 works in the body. When blood sugar starts to rise after a person eats, these medicines ...

  2. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety ...

  3. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... medicine or any other medicines. ... Do not keep outdated medicine or medicine no longer ...

  4. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    Tirzepatide (Mounjaro), a similar kind of medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of insulin as blood sugar levels are rising ...

  5. Genetic test predicts response to weight-loss drugs - Mayo Clinic News Network

    Mayo Clinic researchers developed a genetic test that can help predict how people will respond to weight loss medications such as GLP ... GLP-1 drug, liraglutide ...

  6. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    * Intake of any medication (except multivitamins) within 7 days of the study. Exceptions are birth control pill, estrogen and thyroxine replacement, and ...

  7. Tirzepatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    ... glucagon-like peptide-1 (GLP-1) receptor agonist. ... Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other ...

  8. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    ... GLP1 Agonist and GLP-1/ GIP agonist medications. Print details. Share ... It is proposed that participants will wear the devices for a period of 28 days before ...

  9. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    "The magnitude of this difference warrants future studies that could help clarify how GLP-1-based obesity medications and menopausal hormone therapy may ...

  10. A Study Of GLP-1 Receptor Agonists On Reproductive Health In Women - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...